Aurobindo to add Portuguese capsule and tablet capacity through Generis Farmaceutica buy

By Gareth Macdonald

- Last updated on GMT

Image: iStock/dennisvdw
Image: iStock/dennisvdw

Related tags Portugal European union

Aurobindo Pharma Limited has agreed to buy Portugal-based Generis Farmaceutica SA for €135m in a deal that includes a tablet and capsule plant in Amadora.

The takeover – detailed in a post on the Bombay Stock Exchange (BSE) will see Aurobindo’s Dutch subsidiary Agile Pharma BV buy Generis from current owners private equity investor Magnum Capital Partners.

The Hyderabad, India headquartered firm said the acquisition will consolidate its manufacturing operations in Portugal, which includes Aurovitas, Unipessoal LDA and Unipessoal Limitada.

SVP of European operations, Mr V Muralidharan, said the Amadora facility will allow it to “better serve both the Portuguese market and the broader European market, particularly with regard to small volume products.”

The deal is expected to complete in February.

Related topics Drug Delivery Delivery formulations

Related news

Related products

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...